Conmana Versus Pemetrexed-based First-line Induction and Maintenance Chemotherapy in Advanced Lung Adenocarcinoma With EGFR-mutation
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Icotinib (Primary) ; Cisplatin; Pemetrexed
- Indications Adenocarcinoma; Non-small cell lung cancer
- Focus Registrational; Therapeutic Use
- Acronyms Convince
- Sponsors Betta Pharmaceuticals Co Ltd; Zhejiang Betta Pharma
- 02 Jul 2019 Status changed from active, no longer recruiting to completed.
- 23 Aug 2017 Results published in the Annals of Oncology
- 11 Oct 2016 Primary endpoint (Progression Free Survival) has been met, according to results presented at the 41st European Society for Medical Oncology Congress.